spacer
spacer

PDBsum entry 1qad

Go to PDB code: 
protein links
Transferase PDB id
1qad

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
104 a.a. *
Waters ×185
* Residue conservation analysis
PDB id:
1qad
Name: Transferase
Title: Crystal structure of thE C-terminal sh2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase: an sh2 domain mimicking its own substrate
Structure: Pi3-kinase p85 alpha subunit. Chain: a. Fragment: c-terminal sh2 domain. Engineered: yes
Source: Bos taurus. Cattle. Organism_taxid: 9913.
Resolution:
1.80Å     R-factor:   0.158     R-free:   0.236
Authors: P.J.Hoedemaeker,G.Siegal,M.Roe,P.C.Driscoll,J.P.A.Abrahams
Key ref:
F.J.Hoedemaeker et al. (1999). Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. J Mol Biol, 292, 763-770. PubMed id: 10525402 DOI: 10.1006/jmbi.1999.3111
Date:
26-Feb-99     Release date:   27-Oct-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P23727  (P85A_BOVIN) -  Phosphatidylinositol 3-kinase regulatory subunit alpha from Bos taurus
Seq:
Struc:
 
Seq:
Struc:
724 a.a.
104 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1006/jmbi.1999.3111 J Mol Biol 292:763-770 (1999)
PubMed id: 10525402  
 
 
Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
F.J.Hoedemaeker, G.Siegal, S.M.Roe, P.C.Driscoll, J.P.Abrahams.
 
  ABSTRACT  
 
The binding properties of Src homology-2 (SH2) domains to phosphotyrosine (pY)-containing peptides have been studied in recent years with the elucidation of a large number of crystal and solution structures. Taken together, these structures suggest a general mode of binding of pY-containing peptides, explain the specificities of different SH2 domains, and may be used to design inhibitors of pY binding by SH2 domain-containing proteins. We now report the crystal structure to 1.8 A resolution of the C-terminal SH2 domain (C-SH2) of the P85alpha regulatory subunit of phosphoinositide 3-kinase (PI3 K). Surprisingly, the carboxylate group of Asp2 from a neighbouring molecule occupies the phosphotyrosine binding site and interacts with Arg18 (alphaA2) and Arg36 (betaB5), in a similar manner to the phosphotyrosine-protein interactions seen in structures of other SH2 domains complexed with pY peptides. It is the first example of a non-phosphate-containing, non-aromatic mimetic of phosphotyrosine binding to SH2 domains, and this could have implications for the design of substrate analogues and inhibitors. Overall, the crystal structure closely resembles the solution structure, but a number of loops which demonstrate mobility in solution are well defined by the crystal packing. C-SH2 has adopted a binding conformation reminiscent of the ligand bound N-terminal SH2 domain of PI3K, apparently induced by the substrate mimicking of a neighbouring molecule in the crystal.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Ribbon diagram of the crystal structure of C-SH2. The various structural elements are labelled using the nomenclature described by [Eck et al 1993]. The disordered BC loop (residues 39-42) is indicated with a broken line.
Figure 3.
Figure 3. Stereo image of the superposition of the ensemble of NMR conformers and the crystal structure of C-SH2. The backbone of the crystal structure is shown in red, while that of the NMR conformers is shown in blue. The N and C termini are marked. The disordered BC loop (residues 39-42) is replaced by a pseudobond between C' of residue 38 and N of residue 43. The superposition was based on the backbone atoms of residues 11-14, 19-24, 32-37, 43-50, 53-59, 78-86, 103-105.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (1999, 292, 763-770) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21362552 X.Zhang, O.Vadas, O.Perisic, K.E.Anderson, J.Clark, P.T.Hawkins, L.R.Stephens, and R.L.Williams (2011).
Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism.
  Mol Cell, 41, 567-578.
PDB code: 2y3a
19962457 S.B.Gabelli, D.Mandelker, O.Schmidt-Kittler, B.Vogelstein, and L.M.Amzel (2010).
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design.
  Biochim Biophys Acta, 1804, 533-540.  
19962665 B.S.Jaiswal, V.Janakiraman, N.M.Kljavin, S.Chaudhuri, H.M.Stern, W.Wang, Z.Kan, H.A.Dbouk, B.A.Peters, P.Waring, T.Dela Vega, D.M.Kenski, K.K.Bowman, M.Lorenzo, H.Li, J.Wu, Z.Modrusan, J.Stinson, M.Eby, P.Yue, J.S.Kaminker, F.J.de Sauvage, J.M.Backer, and S.Seshagiri (2009).
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.
  Cancer Cell, 16, 463-474.  
19915146 H.Wu, S.C.Shekar, R.J.Flinn, M.El-Sibai, B.S.Jaiswal, K.I.Sen, V.Janakiraman, S.Seshagiri, G.J.Gerfen, M.E.Girvin, and J.M.Backer (2009).
Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.
  Proc Natl Acad Sci U S A, 106, 20258-20263.  
17008718 S.Reich, L.H.Puckey, C.L.Cheetham, R.Harris, A.A.Ali, U.Bhattacharyya, K.Maclagan, K.A.Powell, C.Prodromou, L.H.Pearl, P.C.Driscoll, and R.Savva (2006).
Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high-throughput applications.
  Protein Sci, 15, 2356-2365.  
15322292 P.J.Scharf, J.Witney, R.Daly, and B.A.Lyons (2004).
Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
  Protein Sci, 13, 2541-2546.  
11856834 F.J.Hoedemaeker, R.W.Visschers, A.C.Alting, K.G.de Kruif, M.E.Kuil, and J.P.Abrahams (2002).
A novel pH-dependent dimerization motif in beta-lactoglobulin from pig (Sus scrofa).
  Acta Crystallogr D Biol Crystallogr, 58, 480-486.
PDB code: 1exs
12122014 S.Kim, R.Zagozdzon, A.Meisler, J.D.Baleja, Y.Fu, S.Avraham, and H.Avraham (2002).
Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
  J Biol Chem, 277, 36465-36470.  
11468396 G.Jogl, X.Tao, Y.Xu, and L.Tong (2001).
COMO: a program for combined molecular replacement.
  Acta Crystallogr D Biol Crystallogr, 57, 1127-1134.  
11567151 R.A.Pauptit, C.A.Dennis, D.J.Derbyshire, A.L.Breeze, S.A.Weston, S.Rowsell, and G.N.Murshudov (2001).
NMR trial models: experiences with the colicin immunity protein Im7 and the p85alpha C-terminal SH2-peptide complex.
  Acta Crystallogr D Biol Crystallogr, 57, 1397-1404.
PDB code: 1h9o
11567160 Y.W.Chen (2001).
Solution solution: using NMR models for molecular replacement.
  Acta Crystallogr D Biol Crystallogr, 57, 1457-1461.  
11080645 Y.W.Chen, E.J.Dodson, and G.J.Kleywegt (2000).
Does NMR mean "not for molecular replacement"? Using NMR-based search models to solve protein crystal structures.
  Structure, 8, R213-R220.  
11092918 Y.W.Chen, and G.M.Clore (2000).
A systematic case study on using NMR models for molecular replacement: p53 tetramerization domain revisited.
  Acta Crystallogr D Biol Crystallogr, 56, 1535-1540.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer